Toggle menu
Toggle preferences menu
Toggle personal menu
Not logged in
Your IP address will be publicly visible if you make any edits.

Ergocalciferol

From Pharmacopedia
Revision as of 03:34, 23 May 2026 by MDElliottMD (talk | contribs) (parser-claude batch MedTemplate pre-fill, Top 300 #48)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Ergocalciferol (vitamin D2)
Drisdol, Calcidol; also many OTC preparations

Experience

👥 No personal reports yet
No clinical reports yet

Log in to add your own experience.

Problems

No problems yet. Be the first to suggest one.

+ Add a problem

Titration strategies

No titration strategies yet. Be the first to suggest one.

+ Add a titration strategy

Effects

No effects listed yet. Be the first to suggest one.

+ Add an effect

Relevant anecdote

No anecdotes yet. Share a relevant one.

+ Add an anecdote

Relevant Literature

No literature entries yet.

Log in to submit relevant literature.

Summary
Common uses
Vitamin D deficiency0, Osteomalacia0, Hypoparathyroidism (with calcium)0, Nutritional rickets0
Pharmacy
Starting dose
Deficiency: 50,000 IU PO weekly for 8-12 weeks, then maintenance 800-2,000 IU/day; maintenance OTC dosing typically 800-2,000 IU/d
Preparations
50,000 IU capsules (Rx); 8,000 IU/mL oral solution (Rx); 400-5,000 IU OTC tablets and softgels
US FDA Max
Not strictly fixed; long-term Upper Limit ~4,000 IU/d in adults (Institute of Medicine)
Pharmacology
Routes
Oral
Onset
Days to weeks to raise 25(OH)D; clinical effect on bone over months
Duration
Long; fat-soluble, stored in adipose
Half-life
~24 hours (parent); ~15 days (25(OH)D); 25(OH)D stores persist for months[1]
Bioavailability
~75% (oral; fat-soluble, absorption requires intact biliary/lipid digestion)[1]
Pregnancy
Safe at replacement doses; deficiency is itself a risk in pregnancy and lactation.[citation needed]
Legal status
OTC (low-dose) and Rx-only (50,000 IU and concentrated solutions) in US
Purported mechanism
Ergocalciferol (D2) and cholecalciferol (D3) are hydroxylated in the liver by CYP2R1 to 25-hydroxyvitamin D (the storage form measured clinically) and then in the kidney by CYP27B1 to 1,25-dihydroxyvitamin D (calcitriol), the active hormone that binds the vitamin D receptor (VDR) to drive transcription of genes governing intestinal calcium absorption, bone mineralization, and broad immunomodulation.0 D3 (cholecalciferol) is more potent at raising serum 25(OH)D per dose; D2 remains widely prescribed in the US Rx 50,000 IU formulation[1].

References

  1. 1.0 1.1 1.2 FDA Prescribing Information, Drisdol (ergocalciferol), Sanofi-Aventis, current revision. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/006535s029lbl.pdf